Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.37
+0.36 (3.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Keros Therapeutics Revenue

In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth. Keros Therapeutics had revenue of $385.00K in the quarter ending December 31, 2025, a decrease of -87.34%.

Revenue (ttm)
$244.06M
Revenue Growth
+6,774.96%
P/S Ratio
0.92
Revenue / Employee
$3,128,987
Employees
78
Market Cap
224.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025244.06M240.51M6,774.96%
Dec 31, 20243.55M3.40M2,250.99%
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Fennec Pharmaceuticals 44.64M
Voyager Therapeutics 40.37M
Orchestra BioMed Holdings 33.48M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Artiva Biotherapeutics 251.00K
Revenue Rankings

KROS News

More News